Literature DB >> 31278576

Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Kazuto Kozaka1, Satoshi Kobayashi2, Norihide Yoneda3, Azusa Kitao3, Kotaro Yoshida3, Dai Inoue3, Takahiro Ogi3, Wataru Koda3, Yasunori Sato4, Toshifumi Gabata3, Osamu Matsui3.   

Abstract

OBJECTIVES: To determine the imaging and clinicopathological features of MRI doughnut-like nodules (HBP-doughnut nodules), hyperintense at the hepatobiliary phase (HBP) after injection of gadoxetic acid (EOB) and without arterial-phase hyperenhancement (APHE) in cirrhotic liver.
METHODS: The Institutional Review Board approved this retrospective study and informed consent was waived. We enrolled 309 consecutive patients with liver cirrhosis who were examined by EOB-MRI, dynamic CT, and angiography-assisted CT between 2008 and 2012 and searched for HBP-doughnut nodules. We evaluated imaging characteristics including haemodynamics and signal intensity of MRI, pathological findings, and frequency of malignant transformation.
RESULTS: One hundred and one HBP-doughnut nodules without APHE were identified in 18 patients (6%), including seven of 59 (12%) patients with hepatitis-B-virus-related, nine of 230 (3.9%) with hepatitis-C-virus-related, and two of 33 (6.1%) with alcoholic cirrhosis. All nodules showed enhancement peaks in the portal phase, the same or increased intranodular portal supply on CT during arterial portography, and the same or decreased intranodular arterial supply on CT during hepatic arteriography. On T2-weighted and diffusion-weighted images, 37 (36%) and 24 (24%) nodules, respectively, showed hyperintensity predominantly in the central area. Three nodules were diagnosed by fine needle biopsy as non-neoplastic hepatic nodules. Ninety-three of 101 (92%) nodules in 16 patients were followed up during an observation period of 1163 ± 902 days (range 57-2920 days), and none showed malignant transformation.
CONCLUSION: HBP-doughnut nodules without APHE in cirrhotic liver were not infrequent. None became malignant. We propose calling them 'multiacinar cirrhotic nodules' based on the classification by an International Working Party. KEY POINTS: • HBP-doughnut nodules without APHE were seen in 6% of patients with liver cirrhosis. • The enhancement peak of HBP-doughnut nodules without APHE was in the portal phase, which reflected the fact that they were supplied predominantly by the portal vein, based on angiography-assisted CT findings. • None of the HBP-doughnut nodules without APHE in cirrhotic liver became malignant, and in conjunction with limited pathological features, they may be corresponding to multiacinar cirrhotic nodules in the International Working Party classification.

Entities:  

Keywords:  Diagnosis; Gadolinium; Magnetic resonance imaging; Multidetector computed tomography

Mesh:

Substances:

Year:  2019        PMID: 31278576     DOI: 10.1007/s00330-019-06329-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

Review 1.  MR imaging of cirrhotic nodules.

Authors:  G A Krinsky; V S Lee
Journal:  Abdom Imaging       Date:  2000 Sep-Oct

2.  Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.

Authors:  Hiroyasu Fujiwara; Shigeki Sekine; Hiroaki Onaya; Kazuaki Shimada; Rintaro Mikata; Yasuaki Arai
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

3.  Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Ryuuichi Kita; Kazuto Kozaka; Wataru Koda; Satoshi Kobayashi; Toshifumi Gabata; Hiroko Ikeda; Yasunori Sato; Yasuni Nakanuma
Journal:  Jpn J Radiol       Date:  2012-05-24       Impact factor: 2.374

4.  A case of idiopathic portal hypertension associated with nodular regenerative hyperplasia-like nodule of the liver and mixed connective tissue disease.

Authors:  Shunsuke Hayano; Atsushi Naganuma; Yudai Okano; Yuhei Suzuki; Keisuke Shiina; Haruka Yoshida; Eri Hayashi; Sanae Uehara; Takashi Hoshino; Naomi Miyamae; Tomohiro Kudo; Hiroshi Ishihara; Akira Ogawa; Ken Sato; Satoru Kakizaki
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2016-05

5.  Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.

Authors:  Kazuya Sugimori; Kazushi Numata; Masahiro Okada; Hiromi Nihonmatsu; Shigeo Takebayashi; Shin Maeda; Masayuki Nakano; Katsuaki Tanaka
Journal:  J Med Ultrason (2001)       Date:  2016-10-22       Impact factor: 1.314

Review 6.  Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.

Authors:  Mark D Goodwin; Julie E Dobson; Claude B Sirlin; Beng Ghee Lim; Damien L Stella
Journal:  Radiographics       Date:  2011-10       Impact factor: 5.333

7.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

8.  Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.

Authors:  Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata; Wataru Koda; Tetsuya Minami; Yasuji Ryu; Kazuto Kozaka; Azusa Kitao
Journal:  Eur J Radiol       Date:  2012-08-10       Impact factor: 3.528

9.  Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images.

Authors:  Azusa Kitao; Osamu Matsui; Norihide Yoneda; Kazuto Kozaka; Satoshi Kobayashi; Wataru Koda; Toshifumi Gabata; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma; Ryuichi Kita; Shigeki Arii
Journal:  Radiology       Date:  2012-12       Impact factor: 11.105

10.  Pathomorphological study of HCV antibody-positive liver cirrhosis.

Authors:  K Shimamatsu; M Kage; O Nakashima; M Kojiro
Journal:  J Gastroenterol Hepatol       Date:  1994 Nov-Dec       Impact factor: 4.029

View more
  4 in total

Review 1.  Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.

Authors:  Cathryn L Hui; Marcela Mautone
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

2.  Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.

Authors:  Chenxi Liu; Yan Sun; Yao Yang; Yuemin Feng; Xiaoyu Xie; Lingyu Qi; Keke Liu; Ximing Wang; Qiang Zhu; Xinya Zhao
Journal:  Eur Radiol       Date:  2021-02-03       Impact factor: 5.315

Review 3.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

Review 4.  Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.

Authors:  Federica Vernuccio; Domenico Salvatore Gagliano; Roberto Cannella; Ahmed Ba-Ssalamah; An Tang; Giuseppe Brancatelli
Journal:  Insights Imaging       Date:  2021-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.